Skip to main content

Pacific Biomarkers Teams with Clinigene on Lab Services

NEW YORK (GenomeWeb News) – Pacific Biomarkers today said that it will collaborate with India-based Clinigene International on addressing the biomarker and high-end clinical trial services needs of the pharmaceutical and biotech industry.

Seattle-based Pacific Biomarkers provides biomarker and diagnostic assay services. Among Clinigene's services are cell-based assays and immunoanalytical testing.

"This partnership with Clinigene provides us access to India, an emerging hub for drug development and contract research," Pacific Biomarkers CEO Ronald Helm said in a statement. "Further, Clinigene's state-of-the-art facilities and highly qualified staff help us offer to all of our clients an economic option for conducting their biomarker and specialty clinical lab tests."

Further terms of the alliance were not disclosed.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.